Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Lung Neoplasms 5Colorectal Neoplasms 5Prostatic Neoplasms 3Hematologic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Motor Activity 2Lymphoma, Non-Hodgkin 2Hodgkin Disease 2Hematopoietic and Lymphoid System Neoplasm 2Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Sleep Wake Disorders 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Obesity 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Melanoma 1Malignant Solid Neoplasm 1Malignant Primary Pelvic Neoplasm 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Leukemia 1Inflammatory Breast Neoplasms 1Hematopoietic and Lymphatic System Neoplasm 1Heart Defects, Congenital 1

Interventions

pembrolizumab 18Nivolumab 13avelumab 10Ipilimumab 7Specimen Handling 6cemiplimab 5atezolizumab 5Magnetic Resonance Spectroscopy 5Biopsy 5Radiotherapy 3Cyclophosphamide 3prednylidene 2poly ICLC 2lutetium Lu 177 dotatate 2fludarabine phosphate 2fludarabine 2durvalumab 2deltacortene 2aldesleukin 2Radiosurgery 2Prednisone 2Interleukin-2 2Immunoglobulin G 2Docetaxel 2CTLA-4 Antigen 2Bevacizumab 2tocilizumab 1talimogene laherparepvec 1sargramostim 1relatlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Merkel Cell × Exercise Test × 1 year × Clear all
NCT06008977 2026-03-25

EX-BOOST

AdventHealth Translational Research Institute

Phase NA Active not recruiting
12 enrolled
Dermatologic

Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡